Aspire Biopharma Holdings, Inc. (ASBP) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Aspire Biopharma Holdings, Inc. (ASBP).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $0.324

Daily Change: +$0.0039 / 1.20%

Daily Range: $0.32 - $0.36

Market Cap: $16,511,969

Daily Volume: 329,116

Performance Metrics

1 Week: -12.52%

1 Month: 2.27%

3 Months: 1.93%

6 Months: -97.17%

1 Year: -96.95%

YTD: -97.10%

Details

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.

Selected stocks

Quhuo Limited - American Depository Shares (QH)

DXC Technology Company (DXC)

Scienjoy Holding Corporation (SJ)